Evidence map›Paper›PMID 28674118›Full record

ReviewClinical cancer research : an official journal of the American Association for Cancer Research2017

Retinoblastoma and Neuroblastoma Predisposition and Surveillance.

Junne Kamihara, Franck Bourdeaut, William D Foulkes, Jan J Molenaar, Yaël P Mossé, Akira Nakagawara, Andreu Parareda, Sarah R Scollon, Kami Wolfe Schneider, Alison H Skalet and 4 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 113 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 2 syntheses or guidelines pooled it, 227 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Update on Retinoblastoma Therapies.Medicina (Kaunas, Lithuania) · 2025
    Review
  16. Pediatric Cancer Predisposition and Surveillance Update: Summary Perspective and Future Directions.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Review
  17. Retinoma: An overview.Pediatric investigation · 2025
    Review
  18. Article
  19. Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  20. Article

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Junne KamiharaDana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts.
Franck BourdeautInstitut Curie, Integrated Cancer Research Site, Paris, France.
William D FoulkesHuman Genetics, Medicine and Oncology, McGill University, Montreal, Québec, Canada.
Jan J MolenaarPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Yaël P MosséChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Akira NakagawaraSaga Medical Center Koseikan, Saga, Japan.
Andreu PararedaSant Joan de Deu, Barcelona Children's Hospital, Barcelona, Catalonia, Spain.
Sarah R ScollonBaylor College of Medicine, Houston, Texas.
Kami Wolfe SchneiderChildren's Hospital Colorado, Aurora, Colorado.
Alison H SkaletCasey Eye Institute, Oregon Health and Science University, Portland, Oregon.
Lisa J StatesChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Michael F WalshMemorial Sloan Kettering Cancer Center, New York, New York.
Lisa R DillerDana-Farber Cancer Institute, Boston Children's Hospital, Boston, Massachusetts.
Garrett M BrodeurChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania. Brodeur@email.chop.edu.
Children's Hospital of Philadelphia · USBaylor College of Medicine · USMemorial Sloan Kettering Cancer Center · US

Funding

Pediatric Scholars ProgramK12HD043245 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI ST. GEME, JOSEPH W. · 2003 to 2022
$7.4M
MOLECULAR GENETIC ANALYSIS OF NEUROBLASTOMAR01CA039771 · NCI · WASHINGTON UNIVERSITY · PI BRODEUR, GARRETT M · 1985 to 2013
$4.2M
NCI NIH HHS R01 CA039771NICHD NIH HHS K12 HD043245
6 · The paper itself

Abstract

Retinoblastoma (RB) is the most common intraocular malignancy in childhood. Approximately 40% of retinoblastomas are hereditary and due to germline mutations in the

Indexed as

Anaplastic Lymphoma KinaseGenetic Predisposition to DiseaseHomeodomain ProteinsHumansNeuroblastomaNeuroimagingPinealomaReceptor Protein-Tyrosine KinasesRetinoblastomaRetinoblastoma Binding ProteinsTranscription FactorsUbiquitin-Protein LigasesALK protein, humanAnaplastic Lymphoma KinaseHomeodomain ProteinsNBPhox proteinRB1 protein, humanReceptor Protein-Tyrosine KinasesRetinoblastoma Binding ProteinsTranscription FactorsUbiquitin-Protein Ligases

Identifiers

PMID28674118
PMCPMC7266051
OpenAlexW2725857922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.